Skip to main content
Home
Search
Multi-scale Atlas
NEW
Search for Drug ADMET Endpoint Profile (DAE)
NEW
Search for Drug Pharmacogenomic Perturbation Map (DPP)
NEW
Search for Drug-Molecule Activity Atlas (DMA)
NEW
Drug Development Portfolio
Search for Drug
Search for Combinatorial Drug (CBD)
Search for Repurposed Drug (RPD)
Drug-interacting Molecule
Search for Drug Therapeutic Target (DTT)
Search for Drug Transporter (DTP)
Search for Drug-Metabolizing Enzyme (DME)
Search for Drug Off-target (DOT)
Disease
Search for Disease
Download
Help
About
Details of the Drug Formulaction
General Information of Drug Formulation (ID: F03327)
Formulation Name
Carbamazepine 200 mg tablet
Company
NCS HealthCare of KY, Inc dba Vangard Labs
Pharmaceutical Drug(s) in Formulation
Drug Name
Drug ID
Indication
ICD 11
Status
Carbamazepine
DMZOLBI
Epilepsy
8A60-8A68
Approved
--------------------
Pharmaceutical Excipient(s) in Formulation
Excipient Name
Excipient ID
PubChem CID
Functional Classification
Carmellose sodium
E00625
Not Available
Disintegrant
Glycerin
E00026
753
Antimicrobial preservative; Emollient; Flavoring agent; Humectant; Lubricant; Plasticizing agent; Solvent; Suppository base; Tonicity agent; Viscosity-controlling agent
Lactose monohydrate
E00393
104938
Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate
E00208
11177
lubricant
Silicon dioxide
E00670
Not Available
Anticaking agent; Opacifying agent; Viscosity-controlling agent
--------------------